Artelo Biosciences, Inc. (ARTL): Total Assets
$2.80M
As of 2025-12-31
$6.46M
As of 2026-06-30
-48.4%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.80M | -40.4% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $4.70M | -64.0% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $13.04M | -36.1% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $20.42M | -27.7% | 2024-03-25, Balance as of period end |
| 2021-12-31 | $28.25M | n/a | 2023-03-31, Balance as of period end |
| 2021-08-31 | $12.63M | +188.7% | 2023-03-31, Balance as of period end |
| 2020-08-31 | $4.38M | -32.5% | 2021-11-29, Balance as of period end |
| 2019-08-31 | $6.48M | n/m | 2020-11-04, Balance as of period end |
| 2018-08-31 | $397.0K | -30.9% | 2019-12-18, Balance as of period end |
| 2017-08-31 | $574.3K | n/m | 2018-11-29, Balance as of period end |
| 2016-08-31 | $3.6K | -78.9% | 2017-11-29, Balance as of period end |
| 2015-08-31 | $17.0K | +15.6% | 2016-11-29, Balance as of period end |
| 2014-08-31 | $14.7K | n/a | 2015-12-11, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | $2.80M | -40.4% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.81M | -49.4% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $2.93M | +9.7% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.67M | -25.3% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.97M | +7.7% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $2.60M | -28.5% |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $3.03M | -80.6% |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | $3.07M | +90.2% |
Compare ARTL, BFRG, NTHI, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗